跳至主要内容
临床试验/NCT01291186
NCT01291186已完成不适用

The Effect of BMI on Median Effective Dose (ED50) of Intrathecal Hyperbaric Bupivacaine for Total Knee Replacement Arthroplasty

Seoul Medical Center1 个研究点 分布在 1 个国家目标入组 108 人开始时间: 2010年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
108
试验地点
1
主要终点
success of spinal anesthesia

研究概览

简要总结

The effect of Body-mass index (BMI) on requirements of local anesthetics used in spinal anesthesia has not been well established. The investigators tried to quantify the effect of BMI on spinal anesthesia by comparing the median effective dose of intrathecal bupivacaine between two different BMI groups.

详细描述

The effect of BMI on requirements of local anesthetics used in spinal anesthesia has not been well established. The investigators tried to quantify the effect of BMI on spinal anesthesia by comparing the median effective dose (ED50)of intrathecal bupivacaine between two different BMI groups. The investigators determined the ED50 and ED 95 of intrathecal hyperbaric bupivacaine of subjects with BMI below 27.5 kg/m2, and subjects with BMI over 27.5 kg/m2, respectively. By comparing the difference of ED50 and ED95 between the groups, the investigators tried to quantify the effect of BMI on the bupivacaine dose requirement.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Double (Participant, Investigator)

入排标准

年龄范围
40 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing elective total knee replacement arthroplasty

排除标准

  • Patients with previous spine surgery, diabetic and other neuropathy, skin infection at the site of injection, allergy to bupivacaine and other common contraindications for spinal anesthesia were excluded from this study.
  • The patients with height less than 140 cm or more than 160 cm, body-mass index (BMI) less than 20 or greater than 35 were also excluded.

研究组 & 干预措施

BPV9NO

Experimental

干预措施: BPV9NO (Drug)

BPV6NO

Experimental

干预措施: BPV6NO (Drug)

BPV7NO

Experimental

干预措施: BPV7NO (Drug)

BPV8NO

Experimental

干预措施: BPV8NO (Drug)

BPV10NO

Experimental

干预措施: BPV10NO (Drug)

BPV11NO

Experimental

干预措施: BPV11NO (Drug)

BPV6O

Active Comparator

干预措施: BPV6O (Drug)

BPV7O

Active Comparator

干预措施: BPV7O (Drug)

BPV8O

Active Comparator

干预措施: BPV8O (Drug)

BPV9O

Active Comparator

干预措施: BPV9O (Drug)

BPV10O

Active Comparator

干预措施: BPV10O (Drug)

BPV11O

Active Comparator

干预措施: BPV11O (Drug)

结局指标

主要结局

success of spinal anesthesia

时间窗: every ten minutes during the surgery

a bilateral T12 sensory level to pinprick within 10 min of the intrathecal drug administration with no additional epidural anesthetics required during the surgery

次要结局

  • time to first request for supplemental analgesia(every ten minutes during and after surgery)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验